Skip to main content
Log in

PET imaging of sympathetic innervation with [18F]Flurobenguan vs [11C]mHED in a patient with ischemic cardiomyopathy

  • Images that Teach
  • Published:
Journal of Nuclear Cardiology Aims and scope

A Correction to this article was published on 02 January 2020

This article has been updated

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1

Change history

  • 02 January 2020

    At time of initial publication, the USAN Council had assigned the generic name for LMI1195 as Flurobenguan. However, the Council has since changed and finalized this compound name as Flubrobenguane which is recommended as the generic name to be used in the future.

References

  1. Stecker EC, Vickers C, Waltz J, et al. Population-based analysis of sudden cardiac death with and without left ventricular systolic dysfunction. J Am Coll Cardiol 2006;47:1161-6. https://doi.org/10.1016/j.jacc.2005.11.045.

    Article  PubMed  Google Scholar 

  2. Jacobson AF, Senior R, Cerqueira MD, et al. Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. J Am Coll Cardiol 2010;55:2212-21. https://doi.org/10.1016/j.jacc.2010.01.014.

    Article  PubMed  Google Scholar 

  3. Fallavollita JA, Heavey BM, Luisi AJ, et al. Regional myocardial sympathetic denervation predicts the risk of sudden cardiac arrest in ischemic cardiomyopathy. J Am Coll Cardiol 2014;63:141-9. https://doi.org/10.1016/j.jacc.2013.07.096.

    Article  PubMed  Google Scholar 

  4. Hall AB, Ziadi MC, Leech JA, et al. Effects of short-term continuous positive airway pressure on myocardial sympathetic nerve function and energetics in patients with heart failure and obstructive sleep apnea: a randomized study. Circulation 2014;130:892-901. https://doi.org/10.1161/CIRCULATIONAHA.113.005893.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

Jason Zelt is an MD/PhD student supported in part by the Vanier Canada Graduate Scholarship, The University of Ottawa, and by a government/industry Grant from the Ontario Research Fund (ORF RE07-021) (industry partner: Lantheus Medical Imaging). The latter also supported this work. Rob Beanlands is a Career Investigator supported by the Heart and Stroke Foundation of Ontario (HSFO), a Tier 1 Chair in Cardiac Imaging Research at the University of Ottawa and Vered Chair in Cardiology at the University of Ottawa Heart Institute. Lisa Mielniczuk is a Mid-career Clinician Scientist supported by HSFO and Tier 2 Chair in HF Research at the University of Ottawa.

Disclosure

Rob S. B. Beanlands and Robert A. deKemp received unrestricted grant funding from Lantheus Medical Imaging (LMI) for this study. Rob S. B. Beanlands is a consultant for LMI. Cesare Orlandi and Simon Robinson are employees of LMI. Jason G. E. Zelt, Lisa M. Mielniczuk, Tayebeh Hadizad, Olga Walter, and Linda Garrard declare they have no conflict of interest related to this study.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Robert A. deKemp PhD.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zelt, J.G.E., Mielniczuk, L.M., Orlandi, C. et al. PET imaging of sympathetic innervation with [18F]Flurobenguan vs [11C]mHED in a patient with ischemic cardiomyopathy. J. Nucl. Cardiol. 26, 2151–2153 (2019). https://doi.org/10.1007/s12350-018-01527-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12350-018-01527-5

Keywords

Navigation